ChartMill assigns a Buy % Consensus number of 83% to LPCN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-24 | Alliance Global Partners | Initiate | Buy |
| 2023-07-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2021-08-26 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-27 | HC Wainwright & Co. | Maintains | Buy |
8 analysts have analysed LPCN and the average price target is 7.01 USD. This implies a price increase of 121.91% is expected in the next year compared to the current price of 3.16.
The consensus rating for LIPOCINE INC (LPCN) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering LIPOCINE INC (LPCN) is 8.